The independent platform for news, articles and advice for professionals in laboratory medicine

NEWS

Source LDPath expands AI capabilities with Ibex Medical Analytics

Source LDPath expands AI capabilities with Ibex Medical Analytics

AI cancer diagnostics firm Ibex Medical and Source LDPath have announced a new agreement to expand the deployment of artificial intelligence to the entire pathology network at Source.

The expansion builds on Ibex's previous work with LDPath, which was acquired earlier this year by Source to create Source LDPath, one of the largest private providers of cellular and digital pathology services in the UK. The deployment will include new AI-powered tools for diagnosing multiple tissue types and support pathologists with improved diagnostic accuracy and efficiency.

With around 275,000 women undergoing breast biopsy and 100,000 men undergoing prostate biopsy in the UK each year, NHS pathology services remain under significant pressure resulting from a shortage of pathologists, rising case numbers, and a post-pandemic backlog.  

Ibex's Galen platform will be made available to the entire Source network, spanning more than 200 pathologists who will use Ibex's AI-powered workflows integrated into an in-house developed LIS and reporting system.

The Galen suite of solutions from Ibex is the first and most widely deployed AI technology in pathology, used in routine clinical practice in laboratories, hospitals, and health systems worldwide. It supports pathologists in a variety of tasks during the diagnosis of breast, prostate, and gastric biopsies and helps improve the accuracy of cancer diagnosis, reduce turnaround time, boost productivity, and improve user experience for pathologists. Galen demonstrated outstanding outcomes across multiple clinical studies performed on various tissue types and diagnostic workflows (references available).

"We are building the largest private digital pathology network in the UK, helping in mitigating the impact of the continued shortage of pathologists and addressing the NHS backlog in cancer diagnosis, which has become a national priority," added Sanj Lallie, Commercial and Digital/AI Director, Source LDPath. "We are proud to expand our diagnostic capabilities with Ibex's world-renowned AI technology, adopted at scale across our network to help ensure that cancer patients receive an accurate and timely diagnosis."

Dr Alistair Robson, FRCPath, DipRCPath and Medical Director of Source LDPath added: "I have seen first-hand how transformative and impactful AI-powered tools can be for a pathologist's work. I am encouraged by the continued rollout of Ibex AI across UK hospital trusts and am looking forward to seeing Ibex's newly announced biomarker scoring tools helping breast pathologists improve diagnosis of IHC stained slides."

FEATURES

The transition to digital pathology is happening: How are you going digital?

Sanj Lallie of Source LDPath looks at the benefits of transitioning to a digital pathology workflow and charts a vision of a virtual histopathology department for every NHS trust.

Predicting risk of pre-eclampsia with PIGF-based testing

Pre-eclampsia remains a common complication during pregnancy, but the methods used to initially determine the presence of the disease still rely on simple non-specific parameters. Testing for placental growth factor has huge potential to improve management of a condition that is challenging to diagnose explains Dawn Hannah, clinical educator at Quidel.

On-demand printing in a world of developing technology

The emerging technology of on-demand printers can offer significant benefits to histology laboratories and pathology procedures, while also facilitating error reduction, explains Lauraline Winter.

How can POCT help to alleviate NHS winter pressures?

New point-of-care testing technology boasts rapidly expanding capabilities, and a new piece of equipment from HORIBA offers under-pressure NHS frontline staff laboratory-accurate tests within minutes, allowing them to make quicker treatment decisions.

PRODUCTS

LATEST ISSUEs

December 2022
January 2022
September 2020

Upcoming Events

Microbiology Society Annual Conference 2023

Birmingham International Convention Centre.
17-20 April 2023

British Society for Microbial Technology Annual Microbiology Conference

Royal Air Force Museum, Hendon, London
11 May 2023

Microscience Microscopy Congress 2023 (mmc 2023, incorporating EMAG 2023)

Manchester Central Conference Centre
4-6 July 2023

IBMS Congress 2023

ICC Birmingham
25-28 September 2023

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

Microbiology Society Annual Conference 2023

Birmingham International Convention Centre.
17-20 April 2023

British Society for Microbial Technology Annual Microbiology Conference

Royal Air Force Museum, Hendon, London
11 May 2023

Microscience Microscopy Congress 2023 (mmc 2023, incorporating EMAG 2023)

Manchester Central Conference Centre
4-6 July 2023

IBMS Congress 2023

ICC Birmingham
25-28 September 2023

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999 Fax: 01892 616177
www.step-communications.com
© 2022 Step Communications Ltd. Registered in England. Registration Number 3893025